Navigation Links
Paradigm Spine Closes $21.5 Million Financing and Announces Promotion of Matt Stuttle to Position of Vice President, US Sales
Date:7/27/2009

NEW YORK, July 27 /PRNewswire/ -- Paradigm Spine, LLC, a developer of innovative non-fusion spinal implant solutions, announced that it has completed a $21.5 million financing, consisting of a $15mm debt facility and $6.5mm equity. Fifth Third Bank was the sole lender in the $15mm venture debt funding. The $6.5 mm of equity was led by Praefinium Group, a global asset management group specializing in high-growth opportunities, and Trevi Health Ventures, a venture capital firm specializing in healthcare investments.

The proceeds from this financing will be used to strengthen the US sales infrastructure, fund the Company's ongoing US clinical trial of the coflex((R)) device, and drive further international expansion of the company's product portfolio. The Company believes this financing will carry it through to profitability in 2010.

Marc R. Viscogliosi, Chairman and CEO of Paradigm Spine, LLC, said "Paradigm's ability to raise capital despite this current economic situation reinforces the strength and quality of our organization, and the confidence our investors have in the success of the company. Paradigm has demonstrated a strong track record over the past 4 years, with sales growing at a CAGR of over 60% from 2005 - 2008. Worldwide revenues grew 63% 2Q09 vs. 2Q08 and growth was more than 15% when comparing sequentially 2Q09 vs. 1Q09. We are particularly pleased with this performance despite economic headwinds and slowing surgical volumes and expect this growth to continue with the expansion of the US Sales team. "

Jeff Thieman, vice president of National Healthcare Finance at Fifth Third Bank added: "We are pleased to do business with a market leader in the advancement of innovative non-fusion spinal implant products. The new capital will support Paradigm as the Company positions itself for future growth. At Fifth Third Bank, we are committed to responsible lending for our commercial clients."

HealthCor Partners has been an investor since 2007 and is a significant shareholder of Paradigm Spine. Jeff Lightcap, Senior Managing Director at HealthCor and a member of the Paradigm Board said "HealthCor has watched the compelling value proposition of Paradigm Spine increase over the past few years, from a small, R&D focused product development company to an established operational business with a full product portfolio. We believe this financing will take the Company even further to the next level, enabling achievement of significant sales, clinical and regulatory milestones in the next few years."

Paradigm Spine is also pleased to announce the promotion of Matt Stuttle to the position of Vice President, US Sales. Matt joined Paradigm Spine in June of 2008 as an Area Sales Director for the Western US with over 12 years of Pharmaceutical and Medical Device experience. He has held various positions in Sales, Sales Management, and Director level roles with Forest Pharmaceuticals, Kyphon, and most recently Medtronic Spine and Biologics.

"Promoting Matt to Vice President, US Sales, creates a results oriented culture and strong foundation for our US Sales team," commented Chris Hughes, President, US. "He will continue to add extensive industry knowledge, surgeon and sales force relationships to the US infrastructure, and he will be instrumental in strategically executing our US sales plan."

About Paradigm Spine, LLC

Paradigm Spine is a company focused on the design, development and marketing of innovative non-fusion solutions for the treatment of spinal conditions and diseases. The company's mission is to provide only "Best in Class" products and services to Spine Surgeons and to be above all, "Surgeon Centric, Indication Specific and Data Driven".

The company is concentrating on building a multi-product non-fusion portfolio. The company's signature product is the coflex((R)) interlaminar/interspinous functionally dynamic stabilization device, currently being used in over 40 countries.

The company is currently conducting a multi-center IDE clinical trial of the coflex((R)) implant in the United States. The FDA cleared the company's DSS(TM) system in 2008, which is the company's first product to be marketed in the United States. Paradigm Spine's wholly owned subsidiary, Fourth Dimension Spine is developing a portfolio of non-fusion scoliosis technologies.

For more information please visit: www.paradigmspine.com


'/>"/>
SOURCE Paradigm Spine, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Changing Paradigms in Hereditary Angioedema: A Focus on Timely Diagnosis and New Therapies
2. Changing Paradigms in Hereditary Angioedema: Pathophysiology, Diagnosis and Treatment
3. The Beryl Companies Reinvents Call Center, Shatters Old Paradigm
4. National Womens Health Report Addresses Issues of Uninsured Plus New Paradigms of Care
5. New CME guidelines advise paradigm shift in physician education
6. Cancer Researcher Dan Von Hoff, M.D. Advocates for "Context of Vulnerability," A Powerful New Paradigm for Targeted Drug Development
7. Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift
8. DIA Conference to Provide New Paradigms in Evidence-Based Medicine and Health Technology Assessment
9. New KLRI Reports Shows Longevity Science Moving Beyond Studying the Obvious to the Downward Spiral Paradigm in the Aging Process
10. Siemens New Ultrasound Platform Revolutionizes the Paradigm of Echocardiography
11. Paradigm shift: Switch for programmed cell death promotes spread of glioblastoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
(Date:6/24/2016)... ... 2016 , ... Advanced Plastic Surgery Institute ( http://www.advancedplasticsurgeryinstitute.com ), ... official Medspa Sponsor. Dr. Josh Olson, a board-certified plastic surgeon, owns the practice, ... says the decision to support the pageant in an official capacity is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Southern Illinois ... are co-chairs for the Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy ... Gateway Convention Center in Collinsville. , They expect to treat approximately ...
(Date:6/24/2016)... Austin, TX (PRWEB) , ... June 24, 2016 , ... ... laude graduate, joins Evans Dermatology in the South Lamar location as of July 13, ... Texas Southwestern Medical School. As a medical student, she regularly volunteered at the Agape ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: